Anonymous ID: 7e1076 July 15, 2021, 8:30 a.m. No.72542   🗄️.is 🔗kun

Graphene nanotech neural implant company inbrain Neuroelectronics receives 14.35 million investment

 

https://interhospi.com/graphene-nanotech-neural-implant-company-inbrain-neuroelectronics-receives-e14-35-million-investment/

 

INBRAIN Neuroelectronics, a spin-off Graphene Flagship partners the Catalan Institute of Nanoscience and Nanotechnology (ICN2) and ICREA, Spain, has received a €14.35 million Series A investment, one of the biggest rounds in the Spanish MedTech industry. The investment will allow INBRAIN to bring their novel neurotechnology to humans for the first time.

 

INBRAIN Neuroelectronics was established in 2019, at the intersection between MedTech, DeepTech and Digital Health, with a mission to decode brain signals to develop medical solutions for patients with epilepsy, Parkinson’s disease and other neurological disorders. The company designs small implantable brain intelligent systems – built around an innovative nanoscale graphene electrode – with the ability to interpret brain signals with unprecedented high fidelity, producing a therapeutic response adapted to the clinical condition of each patient.

 

Disruptive technology based on graphene

Existing brain interfaces are based on metals such as platinum and iridium, which impose significant restrictions in terms of miniaturisation and signal resolution, and therefore cause considerable side effects. For this reason, there is a 50% rejection rate in candidate patients. INBRAIN Neuroelectronics uses a disruptive technology based on graphene which will overcome the current limitations of metal-based neural interfaces.

.....

 

Cinzia Spinato, Graphene Flagship Business Developer for Biomedical Applications, said: “INBRAIN is leading the way in the field of graphene-based implantable brain devices, and I hope that this success will raise the interest of new stakeholders and corporates towards the opportunities graphene offers in the healthcare domain. I remember when INBRAIN was born, and it is impressive how they have grown so fast: transforming a laboratory technology into a product – an outstanding milestone. This investment will be fundamental to speed up the development of graphene-based medical devices, which will be tested on patients much earlier than everyone expected.”

 

....

 

INBRAIN Neuroelectronics is bringing a complete technological transformation to the treatment of neurological diseases. Its brain implantable intelligent systems are based on graphene electrodes, which allow miniaturisation to nanoscale fabrication, with the potential to reach single-neuron resolution. The extraordinary properties of graphene – which is light, biocompatible, flexible and extremely conductive – are harnessed in much smaller devices that are safer to implant and can be programmed, upgraded and recharged wirelessly.

 

Driven by artificial intelligence, the implant can learn from the brain of each patient and trigger adaptive responses to deliver personalised neurological therapy. In addition, the use of big data management will permit remote monitoring of the device and data processing.

 

The technology has already been validated in in vitro and in vivo, and biocompatibility and toxicity tests have been successful. Studies on large animals have been completed and the investment will bring the technology to human patients, in collaboration with key neurosurgical and neurological groups in Europe......

 

but - DO YOU BELIEVE THEM???